Literature DB >> 21940174

A sucrose-derived scaffold for multimerization of bioactive peptides.

Venkataramanarao Rao1, Ramesh Alleti, Liping Xu, Narges K Tafreshi, David L Morse, Robert J Gillies, Eugene A Mash.   

Abstract

A spherical molecular scaffold bearing eight terminal alkyne groups was synthesized in one step from sucrose. One or more copies of a tetrapeptide azide, either N(3)(CH(2))(5)(CO)-His-DPhe-Arg-Trp-NH(2) (MSH4) or N(3)(CH(2))(5)(CO)-Trp-Met-Asp-Phe-NH(2) (CCK4), were attached to the scaffold via the copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC) reaction. Competitive binding assays using Eu-labeled probes based on the superpotent ligands Ser-Tyr-Ser-Nle-Glu-His-DPhe-Arg-Trp-Gly-Lys-Pro-Val-NH(2) (NDP-α-MSH) and Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe-NH(2) (CCK8) were used to study the interactions of monovalent and multivalent MSH4 and CCK4 constructs with Hek293 cells engineered to overexpress MC4R and CCK2R. All of the monovalent and multivalent MSH4 constructs exhibited binding comparable to that of the parental ligand, suggesting that either the ligand spacing was inappropriate for multivalent binding, or MSH4 is too weak a binder for a second 'anchoring' binding event to occur before the monovalently-bound construct is released from the cell surface. In contrast with this behavior, monovalent CCK4 constructs were significantly less potent than the parental ligand, while multivalent CCK4 constructs were as or more potent than the parental ligand. These results are suggestive of multivalent binding, which may be due to increased residence times for monovalently bound CCK4 constructs on the cell surface relative to MSH4 constructs, the greater residence time being necessary for the establishment of multivalent binding.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21940174      PMCID: PMC3197697          DOI: 10.1016/j.bmc.2011.08.053

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  32 in total

Review 1.  Molecular imaging.

Authors:  R Weissleder; U Mahmood
Journal:  Radiology       Date:  2001-05       Impact factor: 11.105

2.  Heterobivalent ligands crosslink multiple cell-surface receptors: the human melanocortin-4 and delta-opioid receptors.

Authors:  Josef Vagner; Liping Xu; Heather L Handl; Jatinder S Josan; David L Morse; Eugene A Mash; Robert J Gillies; Victor J Hruby
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

Review 3.  Recent advances in the chemistry of cholecystokinin receptor ligands (agonists and antagonists).

Authors:  P de Tullio; J Delarge; B Pirotte
Journal:  Curr Med Chem       Date:  1999-06       Impact factor: 4.530

Review 4.  Molecular imaging and targeted therapies.

Authors:  David L Morse; Robert J Gillies
Journal:  Biochem Pharmacol       Date:  2010-04-21       Impact factor: 5.858

5.  A solanesol-derived scaffold for multimerization of bioactive peptides.

Authors:  Ramesh Alleti; Venkataramanarao Rao; Liping Xu; Robert J Gillies; Eugene A Mash
Journal:  J Org Chem       Date:  2010-09-03       Impact factor: 4.354

6.  Expression-driven reverse engineering of targeted imaging and therapeutic agents.

Authors:  Robert J Gillies; Victor J Hruby
Journal:  Expert Opin Ther Targets       Date:  2003-04       Impact factor: 6.902

7.  Synthesis and characterization of a Eu-DTPA-PEGO-MSH(4) derivative for evaluation of binding of multivalent molecules to melanocortin receptors.

Authors:  Liping Xu; Josef Vagner; Ramesh Alleti; Venkataramanarao Rao; Bhumasamudram Jagadish; David L Morse; Victor J Hruby; Robert J Gillies; Eugene A Mash
Journal:  Bioorg Med Chem Lett       Date:  2010-03-04       Impact factor: 2.823

8.  Calcium-dependent prolonged effects on melanophores of [4-norleucine, 7-D-phenylalanine]-alpha-melanotropin.

Authors:  M E Hadley; B Anderson; C B Heward; T K Sawyer; V J Hruby
Journal:  Science       Date:  1981-08-28       Impact factor: 47.728

9.  Synthesis and evaluation of bivalent NDP-alpha-MSH(7) peptide ligands for binding to the human melanocortin receptor 4 (hMC4R).

Authors:  Heather L Handl; Rajesh Sankaranarayanan; Jatinder S Josan; Josef Vagner; Eugene A Mash; Robert J Gillies; Victor J Hruby
Journal:  Bioconjug Chem       Date:  2007-06-26       Impact factor: 4.774

10.  4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity.

Authors:  T K Sawyer; P J Sanfilippo; V J Hruby; M H Engel; C B Heward; J B Burnett; M E Hadley
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

View more
  7 in total

1.  Design, Synthesis, and Testing of a Molecular Truck for Colonic Delivery of 5-Aminosalicylic Acid.

Authors:  Suryakiran Navath; Venkataramanarao Rao; Rita-Marie T Woodford; Monica T Midura-Kiela; Ali M Ahad; Ramesh Alleti; Pawel R Kiela; Eugene A Mash
Journal:  ACS Med Chem Lett       Date:  2012-08-01       Impact factor: 4.345

Review 2.  Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016.

Authors:  Mark D Ericson; Cody J Lensing; Katlyn A Fleming; Katherine N Schlasner; Skye R Doering; Carrie Haskell-Luevano
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-29       Impact factor: 5.187

3.  Synthesis and bioactivity of MSH4 oligomers prepared by an A2 + B2 strategy.

Authors:  Dilani Chathurika Dehigaspitiya; Suryakiran Navath; Craig S Weber; Ronald M Lynch; Eugene A Mash
Journal:  Tetrahedron Lett       Date:  2015-06-03       Impact factor: 2.415

4.  Trigonal scaffolds for multivalent targeting of melanocortin receptors.

Authors:  N G R Dayan Elshan; Thanuja Jayasundera; Bobbi L Anglin; Craig S Weber; Ronald M Lynch; Eugene A Mash
Journal:  Org Biomol Chem       Date:  2015-02-14       Impact factor: 3.876

5.  Development of a time-resolved fluorescence probe for evaluation of competitive binding to the cholecystokinin 2 receptor.

Authors:  N G R Dayan Elshan; Thanuja Jayasundera; Craig S Weber; Ronald M Lynch; Eugene A Mash
Journal:  Bioorg Med Chem       Date:  2015-02-26       Impact factor: 3.641

6.  Demonstration of a sucrose-derived contrast agent for magnetic resonance imaging of the GI tract.

Authors:  Gary V Martinez; Suryakiran Navath; Kamini Sewda; Venkataramanarao Rao; Parastou Foroutan; Ramesh Alleti; Valerie E Moberg; Ali M Ahad; Domenico Coppola; Mark C Lloyd; Robert J Gillies; David L Morse; Eugene A Mash
Journal:  Bioorg Med Chem Lett       Date:  2013-02-13       Impact factor: 2.823

7.  Synthesis and characterization of time-resolved fluorescence probes for evaluation of competitive binding to melanocortin receptors.

Authors:  Ramesh Alleti; Josef Vagner; Dilani Chathurika Dehigaspitiya; Valerie E Moberg; N G R D Elshan; Narges K Tafreshi; Nabila Brabez; Craig S Weber; Ronald M Lynch; Victor J Hruby; Robert J Gillies; David L Morse; Eugene A Mash
Journal:  Bioorg Med Chem       Date:  2013-07-02       Impact factor: 3.641

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.